CHENGDU, China, March 24, 2026 /PRNewswire/ -- Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) today announced that the Investigational New Drug (IND) ...
ADCs are a major new market; Company demonstrates ability to discern antibody toxicity from payload toxicity and show ...
Genovis AB announces that it has entered into a non-exclusive, worldwide license agreement with a US-based private biotech company, granting rights to use Genovis' proprietary EndoS2 enzyme technology ...
Since the first ADC hit the market in 2000, the field has made major progress. More than a dozen ADCs are now approved in the U.S., and some have become a preferred or commonly used treatment option ...
Akeso, Inc. (9926.HK) ("Akeso" or the "Company") announced today that it has received clearance from the Center for Drug Evaluation (CDE) of China's National Medical Products Administration (NMPA) to ...
Dr. Brian S. Henick, a medical oncologist at Columbia University Irving Medical Center and director of the phase 1 program and translational research in aerodigestive cancers, outlined in an interview ...
Global Lung Cancer Antibody Drug Conjugates Market Witnessing Exponential Growth Says Kuick Research Delhi, Oct. 14, 2025 (GLOBE NEWSWIRE) -- Global Lung Cancer Antibody Drug Conjugates Market ...
Merck (MRK) and its Japanese partner Daiichi Sankyo announced that the FDA has granted Breakthrough Therapy Designation ("BTD") to their investigational pipeline candidate, raludotatug deruxtecan ...
About a month after Pfizer CEO Albert Bourla, Ph.D., told investors that the Big Pharma’s pipeline pruning was mostly done, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results